Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calcium Administration to Prevent Hypotension Caused by Diltiazem Administration in the Treatment of Atrial Fibrillation With Rapid Ventricular Response

NCT05691959 is registered in ClinicalTrials.gov with Ascension Health as lead sponsor.

NCT NCT05691959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05691959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calcium Administration to Prevent Hypotension Caused by Diltiazem Administration in the Treatment of Atrial Fibrillation With Rapid Ventricular Response
Lead sponsor
Ascension Health
Phase
Phase 2
Overall status
Unknown status
Start date
January 26, 2023
Completion date
January 31, 2025
Enrollment
378 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation with rapid ventricular response, hypotension